Log in to save to my catalogue

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in...

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e86c5c37d3754fcc9a9f58b727d83ea5

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

About this item

Full title

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2021-07, Vol.21 (1), p.1-784, Article 784

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Minichromosome maintenance complex component 6 (MCM6), as an important replication permission factor, is involved in the pathogenesis of various tumors. Here we studied the expression of MCM6 in neuroblastoma and its influence on tumor characteristics and prognosis. Methods Publicly available datasets were used to explore the influence o...

Alternative Titles

Full title

MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e86c5c37d3754fcc9a9f58b727d83ea5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e86c5c37d3754fcc9a9f58b727d83ea5

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-021-08344-z

How to access this item